|
|
Volumn 136, Issue 11, 2010, Pages 1691-1695
|
|
Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: Experience of a single institution
a
|
|
Author keywords
Glioblastoma multiforme; Long term administration; Temozolomide
|
|
Indexed keywords
TEMOZOLOMIDE;
ALKYLATING AGENT;
DACARBAZINE;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
BRAIN BIOPSY;
BRAIN SURGERY;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CLINICAL EFFECTIVENESS;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEASIBILITY STUDY;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL TOXICITY;
GLIOBLASTOMA;
HUMAN;
INFECTION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE CYCLE TREATMENT;
OVERALL SURVIVAL;
PANCYTOPENIA;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
THROMBOCYTOPENIA;
TREATMENT RESPONSE;
ANALOGS AND DERIVATIVES;
BIOPSY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
SAFETY;
SURVIVAL RATE;
VERY ELDERLY;
YOUNG ADULT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BIOPSY;
COMBINED MODALITY THERAPY;
DACARBAZINE;
DISEASE PROGRESSION;
FEMALE;
GLIOBLASTOMA;
HUMANS;
MALE;
MIDDLE AGED;
SAFETY;
SURVIVAL RATE;
YOUNG ADULT;
|
|
EID: 77957608614
PISSN: 01715216
EISSN: None
Source Type: Journal
DOI: 10.1007/s00432-010-0827-6 Document Type: Article |
|
Times cited : (52)
|
|
References (5)
|
